You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD2423 Solution After Multiple Ascending Doses in Young and Elderly Healthy Volunteers
- Disease
- analgaesia
- Drug Name
- AZD2423
- Generic Name
- AZD2423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Oct 5, 2009
- Study Name
- D2600C00002
- Study Id
- D2600C00002
- ClinicalTrials.gov ID
- NCT00977626
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
